Gilead Accounts Payable from 2010 to 2025

GILD Stock  USD 111.53  0.50  0.45%   
Gilead Sciences' Accounts Payable is decreasing over the years with slightly volatile fluctuation. Accounts Payable is expected to dwindle to about 518.2 M. Accounts Payable is the amount Gilead Sciences owes to suppliers or vendors for products or services received but not yet paid for. It represents Gilead Sciences' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1991-03-31
Previous Quarter
537 M
Current Value
903 M
Quarterly Volatility
469.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Gilead Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gilead Sciences' main balance sheet or income statement drivers, such as Interest Expense of 549.9 M, Total Revenue of 30.2 B or Gross Profit of 74.3 M, as well as many indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0268 or PTB Ratio of 7.87. Gilead financial statements analysis is a perfect complement when working with Gilead Sciences Valuation or Volatility modules.
  
Check out the analysis of Gilead Sciences Correlation against competitors.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.

Latest Gilead Sciences' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Gilead Sciences over the last few years. An accounting item on the balance sheet that represents Gilead Sciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Gilead Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Gilead Sciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gilead Sciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Gilead Accounts Payable Regression Statistics

Arithmetic Mean850,016,781
Geometric Mean527,938,718
Coefficient Of Variation40.55
Mean Deviation260,398,441
Median844,000,000
Standard Deviation344,664,041
Sample Variance118793.3T
Range1.3B
R-Value(0.33)
Mean Square Error113289.7T
R-Squared0.11
Significance0.21
Slope(24,000,263)
Total Sum of Squares1781899.5T

Gilead Accounts Payable History

2025518.2 M
2024632.5 M
2023550 M
2022905 M
2021705 M
2020844 M
2019713 M

About Gilead Sciences Financial Statements

Gilead Sciences stakeholders use historical fundamental indicators, such as Gilead Sciences' Accounts Payable, to determine how well the company is positioned to perform in the future. Although Gilead Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Gilead Sciences' assets and liabilities are reflected in the revenues and expenses on Gilead Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Gilead Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable632.5 M518.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.258
Dividend Share
3.08
Earnings Share
0.38
Revenue Per Share
23.059
Quarterly Revenue Growth
0.064
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.